by bmi_wpadmin | May 26, 2023 | BayMedica, Cannabinoids, CBC, Tetrahydrocannabivarin (THCV)
It’s nice when the right thing is also the financially smart thing. For those of us in the cannabis industry, sustainable bioidentical ingredients let us do both. What does a more sustainable industry look like? To the casual observer, the agricultural side of the...
by bmi_wpadmin | Jan 21, 2023 | BayMedica, Partners, Product Actualization
Get ready, there’s a gold rush coming in cannabinoid-infused beverages. Plenty of big players in the CPG and beverage space have seen the market valuations and are developing products to help them stake their own claims. Now, thanks to Baymedica’s newest product...
by bmi_wpadmin | Nov 16, 2022 | BayMedica, Research
The cannabis industry just got one step closer to a long-sought holy grail – finding the perfect, non-intoxicating therapeutic answer to bodily discomfort. New results from a landmark study offer the industry its first clear look at the power of Cannabichromene (CBC)...
by bmi_wpadmin | Sep 15, 2022 | BayMedica
If you have been in the cannabis/cannabinoid industry for any amount of time, you may have encountered the term “entourage effect.” So what exactly is the entourage effect? For starters, it has nothing to do with the—somewhat questionable—2000s TV series. Instead, it...
by bmi_wpadmin | Jul 22, 2022 | BayMedica, Cannabinoids
In the cannabis industry, it’s hard to improve the plant. Nature has crafted a nearly perfect specimen; hearty and multi-purpose, capable of growing around the world and providing fibers, food, and medicine. When a plant can have so many purposes, it’s hard to...
by bmi_wpadmin | Jul 14, 2022 | BayMedica
Jerry P. Griffin, VP of Sales and Marketing at BayMedica, InMed’s subsidiary, is interviewed by Shadd Dales of The Dales Report to talk about the recent B2B sales launch of rare cannabinoid #tetrahydrocannabivarin #d9 #THCV into the health and wellness sector....
Recent Comments